Research scientists are equipping a vaccine with bits of proteins that redirect the immune system’s efforts to particularly struggle most cancers. The vaccine goals to forestall ovarian most cancers tumors from returning, as relapsing most cancers is usually extra aggressive and troublesome to deal with. The newest analysis additionally seeks to grasp why some ovarian most cancers tumors evade the physique’s immune response. Featured specialists are Dr. Keith Knutson, Immunologist and Cancer Vaccine Researcher at Mayo Clinic; Dr. Saranya Chumsri, Hematologist at Mayo Clinic; and Dr. Nora Disis, Director of the Institute of Translational Health Science and the Center for Translational Medicine in Women’s Health at University of Washington.
Subscribe to Tomorrow’s Cure wherever you get your podcasts. Visit https://www.tomorrowscure.com for extra info.
From Mayo Clinic to your inbox, sign-up free of charge: https://mayocl.in/3e71zfi
Visit Mayo Clinic: https://www.mayoclinic.org/appointments?mc_id=us&utm_source=youtube&utm_medium=sm&utm_content=jJxmyMIIXsM&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100504
Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/
Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, previously Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
